ERGR Omics and Bioinformatics ToolboxPrincipal InvestigatorCitation
snmCAT-seq: combined measurement of the transcriptome, DNA methylome, and chromatin accessibility.LuoLuo et al., Cell Genom. 2022
sn-m3C-seq: DNA methylome and chromatin organization (led to U01HG012079; MPIs: Luo, Plath, Zaitlen)LuoLee et al., Nat Methods. 2019
SEC-seq: method that simultaneously measures secreted proteins and associated transcriptomes across thousands of individual cellsPlath and Dino Di Carlo, PhD (CMINT)Udani et al., Nat Nano. 2023
scDesign 2, scDesign3: simulate realistic scRNA-seq data for benchmarking scRNA-seq data analysis toolsJ LiLi et al., Genome Res. 2019
AIDE: improves isoform discoveryJ LiCass et al., Cell Syst. 2019
moutainClimber: identifies alternative transcription start and polyadenylation sitesXiaoQuinones-Valdez et al., Sci Adv. 2022
scAllele: detects nucleotide variants in scRNA-seq data and uncovers cancer-enriched variants with alternative splicingXiaoLiu et al., Genome Biol., 2023
L-Giremi: uncovers RNA editing sites in long-read RNA-seq dataXiaoArneson et al., Comm Biology. 2019
ConsHMM Atlas: annotates the genome into conservation statesErnstJaroszewicz et al., Bioinformatics. 2020
χ-CNN: integrates 3D-chromatin interactions with epigenomic and TF binding data to fine-map likely sources of 3D chromatin interactionErnstKwon et al., Nat Comm. 2021
LECIF: defines regions with shared functional genomics properties in human and mouseErnstVu et al., Bioinformatics. 2023
CSREP: summarizes chromatin states across samples and quantifies differences between samplesErnstJaroszewicz et al, Genome Biol, 202
Chrom-Gene: models epigenetic data at the gene levelErnstJaroszewicz et al, Genome Biol, 202
Full-stack Chrom-HMM:universal annotation of the human epigenomeErnstVu and Ernst, Genome Biol. 2022
cfSNV detects low frequency mutations from cfDNA, cfSort tissue of origin, cfTrack monitors cancer treatment outcomes from exome seq; cfMethyl-seq, cost-effective method for DNA methylation profilingZhouLi et al.,Nat Comm. 2021 PNAS. 2023, Clin Cancer Res. 2022, Stackpole et al., Nat Commun. 2022.